Home / Resource Library / Clinical efficacy and safety of umbralisib, a dual PI3K/CK1 inhibitor, in treatment of hematologic malignancies

Clinical efficacy and safety of umbralisib, a dual PI3K/CK1 inhibitor, in treatment of hematologic malignancies

Article provides an overview of umbralisib in treatment of hematological cancers.